More Nations Bend to the Economic Cost of Covid Zero-Tolerance

Episode Summary

Executive Summary: The episode examines Singapore’s move from zero-COVID to managed endemicity as a test case for reopening in Asia, while contrasting it with China’s continued zero-COVID stance. It explores the public-health, economic, and political tradeoffs of reopening, and argues that China’s prolonged isolation may deepen growth, information, and diplomatic costs.

Main Topics: Singapore as a zero-COVID exit test case (Priority: 5/5): Singapore is presented as a controlled experiment in reopening: highly vaccinated, tightly managed travel protocols, and willing to accept more infections to restore economic activity. China’s continued zero-COVID strategy (Priority: 5/5): The discussion highlights China’s insistence on zero-COVID through major political events, with the implication that reopening may be delayed for years due to legitimacy and control concerns. Economic costs of lockdown and reopening (Priority: 5/5): Singapore’s recession and China’s slowdown show how strict virus containment can damage growth, trade, tourism, and labor markets, forcing governments to reassess policy. Healthcare and vaccine limitations (Priority: 4/5): Even with high vaccination, reopening brings infections and some deaths; weaker immunity and less effective vaccines make this challenge more severe in China. China’s real estate slowdown and broader economic deceleration (Priority: 5/5): Tom Orlick outlines how COVID-zero, energy shortages, and property-sector stress are combining to sharply slow China’s economy and constrain policy choices. Information flow and geopolitical consequences (Priority: 4/5): Extended isolation risks China turning inward, reducing academic, journalistic, and official exchanges, which could worsen misunderstandings and tensions with the outside world.

Key Arguments: Singapore reopened because remaining in lockdown was not viable for one of the world’s most open economies, especially with air transport and tourism heavily damaged. A high vaccination rate alone does not prevent a surge in infections once restrictions ease; governments must be prepared for a rise in cases and some deaths. China has staked significant political legitimacy on zero-COVID, making an early reopening unlikely, especially ahead of the Winter Olympics and Communist Party Congress. The longer China waits to reopen, the harder it may become because the population lacks natural immunity and the healthcare system—especially outside major cities—may be strained. China’s use of older, less effective vaccines increases the difficulty of safely reopening compared with countries using mRNA vaccines. China’s isolation from academics, journalists, and officials risks narrowing its worldview and making global tensions harder to manage. China’s economy is slowing due to three simultaneous pressures: COVID-zero restrictions, energy shortages, and a severe real estate correction. Real estate is so large in China that shifting away from property-led growth will be painful in the short term, even if it is healthier long term. Officials may tolerate slower growth than before, but the new acceptable floor for growth in 2022 is uncertain and consequential for the world.

Data Points: Singapore vaccination threshold for reopening: 80% - Andrew Brown says Singapore decided to reopen once vaccination coverage reached about 80%. Singapore population: About 5.5 million - Used to compare Singapore’s scale with cities like Sydney, Melbourne, and Barcelona. Singapore air transport sector share of GDP: About 12% - The air transport sector and related industries were heavily harmed by lockdowns. Changi Airport throughput during lockdown: 3-4% of normal - Illustrates the depth of Singapore’s pandemic-related economic collapse. Singapore COVID cases after reopening: About 5,000 cases per day at peak; about 3,000 per day later - Shows the expected rise in infections after reopening. Singapore COVID deaths: A few dozen last year; about 10 per day later - Demonstrates that reopening increased deaths even in a highly vaccinated setting. China third-quarter sequential growth: 0.2% - Tom Orlick cites official data showing a severe slowdown. China annualized growth rate from Q3 sequential figure: 0.8% - Used to emphasize how much slower China was growing than usual. China’s pre-COVID growth pace: 5%-7% - Reference point for how sharply growth has weakened. Estimated share of China GDP tied to real estate: More than 25% - Cited from Ken Rogoff to show the scale of property-sector dependence. China’s reopening timing: Not likely next year; restrictions may last many years - Andrew Brown’s assessment of the durability of zero-COVID. China’s major political milestones: Winter Olympics in February; Communist Party Congress at end of year - These events are cited as reasons China is unlikely to reopen soon.

Pivotal Quotes: "This is a laboratory of sorts for how countries can move from zero COVID, chasing down every last infection, to COVID endemic" — Andrew Brown: Describing Singapore as a real-world test case for reopening strategies in Asia. "The longer you leave it, the worse it becomes." — Andrew Brown: On the challenge of reopening after prolonged zero-COVID policies and the build-up of vulnerability. "It's pretty bad, Stephanie." — Tom Orlick: Opening his assessment of the severity of China’s economic slowdown.

Implications: The episode suggests that reopening after zero-COVID is economically necessary but politically and medically risky. For China, the costs of delay may include weaker growth, reduced global engagement, and harder future reopening conditions.